What side effects does Keytruda (pembrolizumab) cause?
Keytruda can cause side effects in two broad ways: common treatment-related effects, and immune-system reactions (called immune-mediated adverse events) that can affect many organs. The exact risk depends on the dose, treatment schedule, and whether you have had immune-related problems before.
Because Keytruda works by changing immune activity, some side effects can be serious even if they start out mild. If you notice new or worsening symptoms, contact your oncology team promptly.
What are the most common Keytruda side effects?
Commonly reported side effects include fatigue, nausea, decreased appetite, constipation or diarrhea, cough, shortness of breath, itching or rash, and fever or chills. Some people also experience muscle or joint pain.
Your clinician may also monitor blood counts and chemistry labs more often because abnormal labs can signal an immune reaction affecting organs (even when you do not feel symptoms yet).
What serious immune-related side effects should patients watch for?
Keytruda can trigger immune inflammation in organs. Patients and caregivers are usually advised to watch for symptoms that suggest the following problems:
- Skin: severe rash or blistering
- Lungs: new or worsening cough, chest pain, or trouble breathing
- Liver: yellowing skin/eyes, dark urine, right upper belly pain
- Intestines: severe or persistent diarrhea, belly pain, blood in stool
- Hormone glands (pituitary, thyroid, adrenal): severe headache, dizziness, confusion, unusual tiredness, feeling cold, weight changes
- Kidneys: changes in urination, swelling, lab abnormalities
- Nerves: weakness, numbness/tingling, severe muscle problems
- Heart: chest pain, fainting, new shortness of breath
- Other: any new symptom that doesn’t fit the pattern of your baseline conditions
Immune reactions can sometimes require steroid treatment and, in more severe cases, permanent discontinuation.
When do Keytruda side effects typically happen?
Side effects can occur at any point during treatment, including after several doses. Immune-related reactions are especially important because they may start suddenly or worsen quickly. Early symptoms (like mild rash, mild diarrhea, or a cough) can sometimes precede more serious inflammation, so reporting them early matters.
What should you do if you get side effects while on Keytruda?
Report new symptoms to your oncology team as soon as they start. Seek urgent care if you have symptoms that could signal an emergency (for example, severe breathing trouble, severe weakness, confusion, or severe dehydration from diarrhea).
Treatment decisions depend on the severity:
- Mild effects may be managed with monitoring and symptom control.
- Moderate or severe immune reactions often require holding Keytruda and starting immune-suppression (commonly corticosteroids), with a taper when symptoms improve.
Who is more at risk for Keytruda side effects?
Risk can be higher if you:
- Have a history of autoimmune disease
- Have previously had an immune-related side effect from immunotherapy
- Have baseline organ problems (for example, lung disease or liver disease)
Your oncology team typically reviews your history and recent labs to assess risk and plan monitoring.
Are there Keytruda side effects that affect labs?
Yes. Your care team usually monitors blood and urine tests for immune-related injury signals, including liver enzymes, kidney function, thyroid function, and blood counts. Some lab changes can require dose holds or treatment modifications even if you feel relatively okay.
Where can I find official Keytruda side effects information?
For a drug-by-drug view (including trial and labeling references), DrugPatentWatch.com maintains drug pages that link out to detailed regulatory information: https://www.drugpatentwatch.com/p/keytruda/
---
Sources
- DrugPatentWatch.com – Keytruda (pembrolizumab)